As demand for new weight loss drugs soars, some employers are making workers track their diet and exercise in hopes of limiting use and keeping costs down.
Obesity
Posted inCost of Care
GLP-1s Are Busting Employer Budgets. Some Are Getting Creative to Lower Costs.
From obesity management programs to rebates and apps, employers are experimenting with new approaches to make GLP-1 costs more sustainable.
Posted inCost of Care
Ozempic Hype Forces Employer Calls on Obesity Coverage
Employers are facing a big dilemma: How do they pay for the new highly effective and popular obesity medications without breaking the bank?
Posted inCost of Care
How Patents Help Keep Obesity Drug Prices Sky-High
A recent JAMA study sheds light on how the manufacturers of a class of popular weight-loss drugs have avoided competition from more affordable generics.
Posted inPublic Health
The Drugs Changing How We Treat Obesity
A new class of drugs can help people lose weight and manage serious health conditions. But they’re also raising difficult questions.